KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Net Income towards Common Stockholders: 2015-2025

Historic Net Income towards Common Stockholders for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $111.1 million.

  • Medpace Holdings' Net Income towards Common Stockholders rose 15.25% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.0 million, marking a year-over-year increase of 18.42%. This contributed to the annual value of $404.4 million for FY2024, which is 42.99% up from last year.
  • Per Medpace Holdings' latest filing, its Net Income towards Common Stockholders stood at $111.1 million for Q3 2025, which was up 23.13% from $90.3 million recorded in Q2 2025.
  • Medpace Holdings' Net Income towards Common Stockholders' 5-year high stood at $117.0 million during Q4 2024, with a 5-year trough of $39.9 million in Q2 2021.
  • In the last 3 years, Medpace Holdings' Net Income towards Common Stockholders had a median value of $90.3 million in 2025 and averaged $91.2 million.
  • Data for Medpace Holdings' Net Income towards Common Stockholders shows a peak YoY increase of 65.67% (in 2021) and a maximum YoY decrease of 1.64% (in 2021) over the last 5 years.
  • Medpace Holdings' Net Income towards Common Stockholders (Quarterly) stood at $50.0 million in 2021, then surged by 37.25% to $68.7 million in 2022, then grew by 14.02% to $78.3 million in 2023, then spiked by 49.45% to $117.0 million in 2024, then rose by 15.25% to $111.1 million in 2025.
  • Its Net Income towards Common Stockholders was $111.1 million in Q3 2025, compared to $90.3 million in Q2 2025 and $114.6 million in Q1 2025.